Regulations.gov document
Response Letter from Pondera Pharmaceuticals, Inc. re Endorhinate PR
Other · FDA-1997-S-0006 · posted Mar 24, 2014
Key facts
| Document ID | FDA-1997-S-0006-1206 |
|---|---|
| Title | Response Letter from Pondera Pharmaceuticals, Inc. re Endorhinate PR |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-1997-S-0006 |
| Posted | Mar 24, 2014 |
| Comment period opens | Mar 24, 2014 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: